- Upper abdominal organ motion
- Cancer survivorship
- Quality of life in patients with enteral feeding tubes
- Quality of life issues for patients with head and neck cancers: hyperfractionated/accelerated radiation therapy and chemoradiation therapy
- Adjuvant therapy for stomach cancer
- Intensity-modulated radiation therapy for stomach cancer
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
Curr Oncol. 2018 Dec;25(6):366-370
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Lancet. 2018 Nov 15;:
Laryngoscope. 2018 Oct 16;:
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
Radiother Oncol. 2018 Sep 29;:
Predictors of early recurrence prior to planned post-operative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy.
Int J Radiat Oncol Biol Phys. 2018 Sep 20;:
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018 Oct 01;102(2):340-352
Support Care Cancer. 2018 Jul 16;:
J Thorac Cardiovasc Surg. 2018 Aug;156(2):847-856
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
Professor, Department of Health Policy, Management & Evaluation, University of Toronto
Staff Radiation Oncologist, Princess Margaret Hospital